Gossamer Bio

Yahoo Finance • 2 days ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story

Yahoo Finance • 20 days ago

Analysts Remain Bullish on Gossamer Bio (GOSS) Citing Undervaluation

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best stocks under $3 to invest in. On February 4, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Gossamer Bio and set a $10 price target on the stock. This ratings confirma... Full story

Yahoo Finance • 4 months ago

Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies c... Full story

Yahoo Finance • 4 months ago

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies c... Full story

Yahoo Finance • 6 months ago

H.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug Prospects

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best Robinhood penny stocks to invest in. The stock has shown strong momentum, rallying by more than 100% year to date. Likewise, on August 19, analysts at H.C. Wainwright reiterated a ‘Buy’ ra... Full story

Yahoo Finance • 6 months ago

Gossamer Bio higher as UBS upgrades on upcoming data catalyst

[Wall Street New York stock exchange stock market] alexsl Shares of Gossamer Bio (NASDAQ:GOSS [https://seekingalpha.com/symbol/GOSS]) traded higher on Wednesday after UBS upgraded the California-based biotech to Buy from Neutral, citing a... Full story

Yahoo Finance • 7 months ago

Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M

* Gossamer Bio press release [https://seekingalpha.com/pr/20189999-gossamer-bio-announces-second-quarter-2025-financial-results-and-provides-business-update] (NASDAQ:GOSS [https://seekingalpha.com/symbol/GOSS]): Q2 GAAP EPS of -$0.17 in-... Full story

Yahoo Finance • 9 months ago

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies compan... Full story

Yahoo Finance • 9 months ago

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

MIAMI, May 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies compan... Full story

Yahoo Finance • 10 months ago

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look at where Gossamer Bio Inc. (NASDAQ:GOSS) stands against other penny stocks to invest in under $1. Earlier on Febr... Full story

Yahoo Finance • last year

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Conference on February 18 & 19, 2025. The Emerging Growth Conference identifies... Full story

Yahoo Finance • last year

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

Emerging Growth MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26, 2024. The Emerging Growth Con... Full story

Yahoo Finance • 2 years ago

Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023

SAN DIEGO, December 13, 2023--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertensi... Full story

Yahoo Finance • 2 years ago

Gossamer Bio Appoints Bob Smith as Chief Commercial Officer

- Mr. Smith is a recognized leader in the commercialization of PAH products, most recently leading sotatercept US pre-launch activities at Merck - - Previously, Mr. Smith led US sales operations for Actelion - SAN DIEGO, December 05, 202... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Gossamer Bio, Inc. (NASDAQ: GOSS) and Encourages Investors to Contact the Firm

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Gossamer Bio, Inc. (NASDAQ: GOSS) on behalf of the company’s investors. Since December 2022, shares of Gossamer’s common stock have decli... Full story

Yahoo Finance • 2 years ago

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Gossamer Bio, Inc.; Urges Gossamer Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Gossamer Bio, Inc. (Nasdaq: GOSS) (“Gossamer” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Go... Full story

Yahoo Finance • 3 years ago

Bullish insiders at Gossamer Bio, Inc. (NASDAQ:GOSS) loaded up on US$1.2m of stock earlier this year

In the last year, multiple insiders have substantially increased their holdings of Gossamer Bio, Inc. (NASDAQ:GOSS) stock, indicating that insiders' optimism about the company's prospects has increased. While insider transactions are not... Full story

Yahoo Finance • 3 years ago

Lineage Cell Therapeutics Appoints Jill Howe as Chief Financial Officer

CARLSBAD, Calif., October 31, 2022--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that... Full story

Yahoo Finance • 4 years ago

‘Squeezable’ AMC, GameStop stocks break out to multi-month highs

Shares of both AMC Entertainment Holdings Inc. and GameStop Corp. surged to multi-month highs Wednesday, as they extended breakouts above previous chart resistance levels.... Full story

Yahoo Finance • 4 years ago

The Co-Founder of Gossamer Bio, Inc. (NASDAQ:GOSS), Faheem Hasnain, Just Bought 3.8% More Shares

Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Faheem Hasnain, recently bought a whopping US$1m worth of stock, at a price of US$7.21. While that only increased their hol... Full story